Form D — Octagon Biotech Opportunities Fund II LP
0002132995-26-000002 · filed Jul 2, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Pooled Investment Fund filings
Offering
- Industry
- Pooled Investment Fund
- Exemptions
- 06b, 3C, 3C.7
- Reported offering amount
- $175,000,000
- Reported amount sold
- $17,800,000
- Minimum investment
- $5,000,000
- Investors
- 5
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Octagon Biotech Opportunities Fund II LP
- CIK
- 2132995
- Entity
- Limited Partnership
- Jurisdiction
- DELAWARE
- Year incorporated
- 2026
- Address
- 654 MADISON AVENUE, FL. 21
NEW YORK, NY 10065 - Phone
- 212-369-2829
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
n/a Octagon Investments GP, LLC · DirectorNew York, NY Find on LinkedIn ↗
-
n/a Octagon Capital Advisors LP · PromoterNew York, NY Find on LinkedIn ↗
-
Dr. Ting Jia · Executive OfficerNew York, NY Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗